nodes	percent_of_prediction	percent_of_DWPC	metapath
Methdilazine—Carbamazepine—epilepsy syndrome	0.312	0.52	CrCtD
Methdilazine—Oxcarbazepine—epilepsy syndrome	0.287	0.479	CrCtD
Methdilazine—Epinastine—Carbamazepine—epilepsy syndrome	0.0279	0.0725	CrCrCtD
Methdilazine—Epinastine—Oxcarbazepine—epilepsy syndrome	0.0257	0.0668	CrCrCtD
Methdilazine—Phenindamine—Oxcarbazepine—epilepsy syndrome	0.0201	0.0521	CrCrCtD
Methdilazine—Cyproheptadine—Carbamazepine—epilepsy syndrome	0.0188	0.0489	CrCrCtD
Methdilazine—Carbamazepine—Phenytoin—epilepsy syndrome	0.0174	0.0451	CrCrCtD
Methdilazine—Mianserin—Oxcarbazepine—epilepsy syndrome	0.0173	0.0451	CrCrCtD
Methdilazine—Carbamazepine—Oxcarbazepine—epilepsy syndrome	0.0148	0.0384	CrCrCtD
Methdilazine—Oxcarbazepine—Carbamazepine—epilepsy syndrome	0.0136	0.0354	CrCrCtD
Methdilazine—Desipramine—Carbamazepine—epilepsy syndrome	0.0125	0.0325	CrCrCtD
Methdilazine—Oxcarbazepine—Clobazam—epilepsy syndrome	0.012	0.0312	CrCrCtD
Methdilazine—Desipramine—Oxcarbazepine—epilepsy syndrome	0.0115	0.0299	CrCrCtD
Methdilazine—Prazepam—Clonazepam—epilepsy syndrome	0.0115	0.0298	CrCrCtD
Methdilazine—Ethopropazine—Carbamazepine—epilepsy syndrome	0.0113	0.0294	CrCrCtD
Methdilazine—Oxcarbazepine—Diazepam—epilepsy syndrome	0.0112	0.029	CrCrCtD
Methdilazine—Trimipramine—Carbamazepine—epilepsy syndrome	0.011	0.0287	CrCrCtD
Methdilazine—Prazepam—Midazolam—epilepsy syndrome	0.0109	0.0284	CrCrCtD
Methdilazine—Dimetacrine—Carbamazepine—epilepsy syndrome	0.0106	0.0275	CrCrCtD
Methdilazine—Prazepam—Clobazam—epilepsy syndrome	0.0105	0.0273	CrCrCtD
Methdilazine—Trimipramine—Oxcarbazepine—epilepsy syndrome	0.0102	0.0265	CrCrCtD
Methdilazine—Imipramine—Carbamazepine—epilepsy syndrome	0.0101	0.0264	CrCrCtD
Methdilazine—Prazepam—Diazepam—epilepsy syndrome	0.00975	0.0254	CrCrCtD
Methdilazine—Dimetacrine—Oxcarbazepine—epilepsy syndrome	0.00974	0.0253	CrCrCtD
Methdilazine—Promethazine—Carbamazepine—epilepsy syndrome	0.00937	0.0244	CrCrCtD
Methdilazine—Imipramine—Oxcarbazepine—epilepsy syndrome	0.00934	0.0243	CrCrCtD
Methdilazine—Alimemazine—Carbamazepine—epilepsy syndrome	0.0092	0.0239	CrCrCtD
Methdilazine—Promethazine—Oxcarbazepine—epilepsy syndrome	0.00863	0.0225	CrCrCtD
Methdilazine—Alimemazine—Oxcarbazepine—epilepsy syndrome	0.00848	0.022	CrCrCtD
Methdilazine—Chlorpromazine—Clobazam—epilepsy syndrome	0.00844	0.0219	CrCrCtD
Methdilazine—Promazine—Carbamazepine—epilepsy syndrome	0.00793	0.0206	CrCrCtD
Methdilazine—Prochlorperazine—Clobazam—epilepsy syndrome	0.00758	0.0197	CrCrCtD
Methdilazine—Promazine—Oxcarbazepine—epilepsy syndrome	0.0073	0.019	CrCrCtD
Methdilazine—Carbamazepine—SCN9A—epilepsy syndrome	9.72e-05	0.0259	CrCbGaD
Methdilazine—Mirtazapine—HRH3—epilepsy syndrome	9.13e-05	0.0243	CrCbGaD
Methdilazine—Imipramine—KCND2—epilepsy syndrome	9.12e-05	0.0243	CrCbGaD
Methdilazine—Carbamazepine—SCN4A—epilepsy syndrome	8.94e-05	0.0238	CrCbGaD
Methdilazine—Prazepam—GABRD—epilepsy syndrome	7e-05	0.0187	CrCbGaD
Methdilazine—Metixene—CHRM3—epilepsy syndrome	7e-05	0.0187	CrCbGaD
Methdilazine—Metixene—CHRM1—epilepsy syndrome	6.53e-05	0.0174	CrCbGaD
Methdilazine—Ethopropazine—CHRM1—epilepsy syndrome	5.95e-05	0.0159	CrCbGaD
Methdilazine—Cyamemazine—CHRM2—epilepsy syndrome	5.73e-05	0.0153	CrCbGaD
Methdilazine—Metixene—CHRM2—epilepsy syndrome	5.33e-05	0.0142	CrCbGaD
Methdilazine—Prazepam—GABRG2—epilepsy syndrome	5.31e-05	0.0141	CrCbGaD
Methdilazine—Cyproheptadine—CHRM3—epilepsy syndrome	5.31e-05	0.0141	CrCbGaD
Methdilazine—Epinastine—HTR7—epilepsy syndrome	5.27e-05	0.014	CrCbGaD
Methdilazine—Mequitazine—CHRM2—epilepsy syndrome	4.98e-05	0.0133	CrCbGaD
Methdilazine—Cyproheptadine—CHRM1—epilepsy syndrome	4.95e-05	0.0132	CrCbGaD
Methdilazine—Propericiazine—ADRA2A—epilepsy syndrome	4.89e-05	0.013	CrCbGaD
Methdilazine—Triflupromazine—CHRM1—epilepsy syndrome	4.88e-05	0.013	CrCbGaD
Methdilazine—Ethopropazine—CHRM2—epilepsy syndrome	4.86e-05	0.013	CrCbGaD
Methdilazine—Epinastine—ADRA2A—epilepsy syndrome	4.52e-05	0.012	CrCbGaD
Methdilazine—Prazepam—GABRB3—epilepsy syndrome	4.27e-05	0.0114	CrCbGaD
Methdilazine—Prazepam—GABRA5—epilepsy syndrome	4.27e-05	0.0114	CrCbGaD
Methdilazine—Mirtazapine—HTR7—epilepsy syndrome	4.15e-05	0.0111	CrCbGaD
Methdilazine—Ethopropazine—BCHE—epilepsy syndrome	4.05e-05	0.0108	CrCbGaD
Methdilazine—Cyproheptadine—CHRM2—epilepsy syndrome	4.04e-05	0.0108	CrCbGaD
Methdilazine—Triflupromazine—CHRM2—epilepsy syndrome	3.98e-05	0.0106	CrCbGaD
Methdilazine—Propiomazine—CHRM3—epilepsy syndrome	3.87e-05	0.0103	CrCbGaD
Methdilazine—Prazepam—GABRB2—epilepsy syndrome	3.74e-05	0.00996	CrCbGaD
Methdilazine—Prazepam—GABRA1—epilepsy syndrome	3.67e-05	0.00977	CrCbGaD
Methdilazine—Propiomazine—CHRM1—epilepsy syndrome	3.61e-05	0.00961	CrCbGaD
Methdilazine—Mirtazapine—ADRA2A—epilepsy syndrome	3.56e-05	0.00948	CrCbGaD
Methdilazine—Mesoridazine—CHRM2—epilepsy syndrome	3.5e-05	0.00932	CrCbGaD
Methdilazine—HRH1—GPCR ligand binding—CHRM3—epilepsy syndrome	3.44e-05	0.00267	CbGpPWpGaD
Methdilazine—HRH1—GPCRs, Class A Rhodopsin-like—BDKRB2—epilepsy syndrome	3.44e-05	0.00267	CbGpPWpGaD
Methdilazine—HRH1—Signaling by GPCR—ACKR4—epilepsy syndrome	3.4e-05	0.00264	CbGpPWpGaD
Methdilazine—HRH1—GPCR downstream signaling—SSTR4—epilepsy syndrome	3.39e-05	0.00263	CbGpPWpGaD
Methdilazine—HRH1—GPCR downstream signaling—SSTR5—epilepsy syndrome	3.39e-05	0.00263	CbGpPWpGaD
Methdilazine—Prochlorperazine—CHRM2—epilepsy syndrome	3.39e-05	0.00902	CrCbGaD
Methdilazine—HRH1—GPCRs, Class A Rhodopsin-like—CNR1—epilepsy syndrome	3.38e-05	0.00262	CbGpPWpGaD
Methdilazine—Triflupromazine—BCHE—epilepsy syndrome	3.32e-05	0.00885	CrCbGaD
Methdilazine—Methotrimeprazine—CHRM3—epilepsy syndrome	3.31e-05	0.00881	CrCbGaD
Methdilazine—HRH1—GPCR ligand binding—CX3CR1—epilepsy syndrome	3.3e-05	0.00256	CbGpPWpGaD
Methdilazine—HRH1—GPCRs, Class A Rhodopsin-like—HTR7—epilepsy syndrome	3.29e-05	0.00255	CbGpPWpGaD
Methdilazine—Promethazine—CHRM3—epilepsy syndrome	3.26e-05	0.00868	CrCbGaD
Methdilazine—HRH1—GPCR downstream signaling—CCR10—epilepsy syndrome	3.25e-05	0.00252	CbGpPWpGaD
Methdilazine—HRH1—GPCR ligand binding—BDKRB1—epilepsy syndrome	3.24e-05	0.00251	CbGpPWpGaD
Methdilazine—HRH1—GPCR ligand binding—CHRM2—epilepsy syndrome	3.24e-05	0.00251	CbGpPWpGaD
Methdilazine—HRH1—GPCR ligand binding—CX3CL1—epilepsy syndrome	3.24e-05	0.00251	CbGpPWpGaD
Methdilazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—epilepsy syndrome	3.21e-05	0.00249	CbGpPWpGaD
Methdilazine—HRH1—GPCR ligand binding—GABBR1—epilepsy syndrome	3.15e-05	0.00244	CbGpPWpGaD
Methdilazine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR2—epilepsy syndrome	3.14e-05	0.00243	CbGpPWpGaD
Methdilazine—HRH1—Class A/1 (Rhodopsin-like receptors)—SST—epilepsy syndrome	3.14e-05	0.00243	CbGpPWpGaD
Methdilazine—Quetiapine—CHRM3—epilepsy syndrome	3.12e-05	0.00831	CrCbGaD
Methdilazine—Methotrimeprazine—CHRM1—epilepsy syndrome	3.08e-05	0.00822	CrCbGaD
Methdilazine—HRH1—Signaling by GPCR—SSTR4—epilepsy syndrome	3.08e-05	0.00239	CbGpPWpGaD
Methdilazine—HRH1—Signaling by GPCR—SSTR5—epilepsy syndrome	3.08e-05	0.00239	CbGpPWpGaD
Methdilazine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—epilepsy syndrome	3.07e-05	0.00238	CbGpPWpGaD
Methdilazine—Mianserin—HTR7—epilepsy syndrome	3.05e-05	0.00812	CrCbGaD
Methdilazine—Promethazine—CHRM1—epilepsy syndrome	3.04e-05	0.0081	CrCbGaD
Methdilazine—HRH1—GPCR ligand binding—HRH3—epilepsy syndrome	3.02e-05	0.00234	CbGpPWpGaD
Methdilazine—Oxcarbazepine—CYP2C19—epilepsy syndrome	3.01e-05	0.00802	CrCbGaD
Methdilazine—HRH1—G alpha (q) signalling events—HTR2A—epilepsy syndrome	2.99e-05	0.00231	CbGpPWpGaD
Methdilazine—HRH1—GPCR ligand binding—OPRM1—epilepsy syndrome	2.97e-05	0.0023	CbGpPWpGaD
Methdilazine—Desipramine—CHRM3—epilepsy syndrome	2.96e-05	0.00788	CrCbGaD
Methdilazine—Carbamazepine—ABCC2—epilepsy syndrome	2.95e-05	0.00787	CrCbGaD
Methdilazine—HRH1—Signaling by GPCR—CCR10—epilepsy syndrome	2.95e-05	0.00229	CbGpPWpGaD
Methdilazine—HRH1—Class A/1 (Rhodopsin-like receptors)—BDKRB2—epilepsy syndrome	2.95e-05	0.00228	CbGpPWpGaD
Methdilazine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL12—epilepsy syndrome	2.95e-05	0.00228	CbGpPWpGaD
Methdilazine—Propiomazine—CHRM2—epilepsy syndrome	2.95e-05	0.00785	CrCbGaD
Methdilazine—Quetiapine—CHRM1—epilepsy syndrome	2.91e-05	0.00775	CrCbGaD
Methdilazine—HRH1—Class A/1 (Rhodopsin-like receptors)—CNR1—epilepsy syndrome	2.89e-05	0.00224	CbGpPWpGaD
Methdilazine—Cyamemazine—HTR2A—epilepsy syndrome	2.87e-05	0.00765	CrCbGaD
Methdilazine—Promazine—CHRM3—epilepsy syndrome	2.87e-05	0.00764	CrCbGaD
Methdilazine—HRH1—GPCR downstream signaling—GRM2—epilepsy syndrome	2.84e-05	0.0022	CbGpPWpGaD
Methdilazine—HRH1—G alpha (q) signalling events—AGT—epilepsy syndrome	2.83e-05	0.0022	CbGpPWpGaD
Methdilazine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR7—epilepsy syndrome	2.82e-05	0.00219	CbGpPWpGaD
Methdilazine—HRH1—GPCR ligand binding—CCR3—epilepsy syndrome	2.81e-05	0.00218	CbGpPWpGaD
Methdilazine—Desipramine—CHRM1—epilepsy syndrome	2.76e-05	0.00735	CrCbGaD
Methdilazine—HRH1—GPCR ligand binding—NPY—epilepsy syndrome	2.74e-05	0.00212	CbGpPWpGaD
Methdilazine—Mirtazapine—SLC6A4—epilepsy syndrome	2.71e-05	0.00723	CrCbGaD
Methdilazine—Promazine—CHRM1—epilepsy syndrome	2.67e-05	0.00712	CrCbGaD
Methdilazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—epilepsy syndrome	2.67e-05	0.00207	CbGpPWpGaD
Methdilazine—Epinastine—HTR2A—epilepsy syndrome	2.65e-05	0.00706	CrCbGaD
Methdilazine—HRH1—GPCR ligand binding—CCL3—epilepsy syndrome	2.64e-05	0.00205	CbGpPWpGaD
Methdilazine—HRH1—GPCR ligand binding—CXCL2—epilepsy syndrome	2.64e-05	0.00205	CbGpPWpGaD
Methdilazine—HRH1—GPCR ligand binding—OXT—epilepsy syndrome	2.64e-05	0.00205	CbGpPWpGaD
Methdilazine—HRH1—GPCR ligand binding—CRH—epilepsy syndrome	2.64e-05	0.00205	CbGpPWpGaD
Methdilazine—Thioridazine—CHRM2—epilepsy syndrome	2.64e-05	0.00703	CrCbGaD
Methdilazine—Thioridazine—HTR7—epilepsy syndrome	2.63e-05	0.007	CrCbGaD
Methdilazine—Fluphenazine—ADRA2A—epilepsy syndrome	2.61e-05	0.00696	CrCbGaD
Methdilazine—Mianserin—ADRA2A—epilepsy syndrome	2.61e-05	0.00696	CrCbGaD
Methdilazine—HRH1—IL-4 Signaling Pathway—AKT1—epilepsy syndrome	2.58e-05	0.002	CbGpPWpGaD
Methdilazine—HRH1—Signaling by GPCR—GRM2—epilepsy syndrome	2.58e-05	0.002	CbGpPWpGaD
Methdilazine—HRH1—GPCR downstream signaling—SSTR3—epilepsy syndrome	2.57e-05	0.00199	CbGpPWpGaD
Methdilazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—epilepsy syndrome	2.53e-05	0.00196	CbGpPWpGaD
Methdilazine—Chlorpromazine—CHRM3—epilepsy syndrome	2.52e-05	0.00672	CrCbGaD
Methdilazine—Methotrimeprazine—CHRM2—epilepsy syndrome	2.52e-05	0.00671	CrCbGaD
Methdilazine—Imipramine—CHRM3—epilepsy syndrome	2.51e-05	0.00669	CrCbGaD
Methdilazine—Promethazine—CHRM2—epilepsy syndrome	2.48e-05	0.00661	CrCbGaD
Methdilazine—HRH1—GPCR downstream signaling—NPY2R—epilepsy syndrome	2.46e-05	0.00191	CbGpPWpGaD
Methdilazine—HRH1—GPCR downstream signaling—CCR8—epilepsy syndrome	2.46e-05	0.00191	CbGpPWpGaD
Methdilazine—HRH1—GPCR downstream signaling—CCR9—epilepsy syndrome	2.46e-05	0.00191	CbGpPWpGaD
Methdilazine—HRH1—GPCR downstream signaling—SSTR1—epilepsy syndrome	2.46e-05	0.00191	CbGpPWpGaD
Methdilazine—HRH1—GPCR downstream signaling—ARHGEF9—epilepsy syndrome	2.46e-05	0.00191	CbGpPWpGaD
Methdilazine—Trifluoperazine—CHRM2—epilepsy syndrome	2.45e-05	0.00652	CrCbGaD
Methdilazine—Epinastine—CYP2D6—epilepsy syndrome	2.42e-05	0.00645	CrCbGaD
Methdilazine—HRH1—GPCR downstream signaling—GRM3—epilepsy syndrome	2.41e-05	0.00187	CbGpPWpGaD
Methdilazine—HRH1—GPCR downstream signaling—GRM4—epilepsy syndrome	2.41e-05	0.00187	CbGpPWpGaD
Methdilazine—Perphenazine—HTR7—epilepsy syndrome	2.41e-05	0.00642	CrCbGaD
Methdilazine—HRH1—GPCR ligand binding—SST—epilepsy syndrome	2.39e-05	0.00185	CbGpPWpGaD
Methdilazine—HRH1—GPCR ligand binding—CCR2—epilepsy syndrome	2.39e-05	0.00185	CbGpPWpGaD
Methdilazine—HRH1—Class A/1 (Rhodopsin-like receptors)—AVP—epilepsy syndrome	2.38e-05	0.00184	CbGpPWpGaD
Methdilazine—Quetiapine—CHRM2—epilepsy syndrome	2.37e-05	0.00633	CrCbGaD
Methdilazine—HRH1—GPCR downstream signaling—SSTR2—epilepsy syndrome	2.37e-05	0.00184	CbGpPWpGaD
Methdilazine—Quetiapine—HTR7—epilepsy syndrome	2.36e-05	0.0063	CrCbGaD
Methdilazine—HRH1—GPCRs, Class A Rhodopsin-like—CCR5—epilepsy syndrome	2.36e-05	0.00183	CbGpPWpGaD
Methdilazine—Chlorpromazine—CHRM1—epilepsy syndrome	2.35e-05	0.00627	CrCbGaD
Methdilazine—Imipramine—CHRM1—epilepsy syndrome	2.34e-05	0.00624	CrCbGaD
Methdilazine—HRH1—GPCR ligand binding—ADRA2A—epilepsy syndrome	2.34e-05	0.00181	CbGpPWpGaD
Methdilazine—HRH1—Signaling by GPCR—SSTR3—epilepsy syndrome	2.33e-05	0.00181	CbGpPWpGaD
Methdilazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6ST—epilepsy syndrome	2.33e-05	0.00181	CbGpPWpGaD
Methdilazine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—epilepsy syndrome	2.31e-05	0.00179	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—PRDM4—epilepsy syndrome	2.3e-05	0.00178	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—PRICKLE1—epilepsy syndrome	2.3e-05	0.00178	CbGpPWpGaD
Methdilazine—HRH1—GPCR downstream signaling—GRM8—epilepsy syndrome	2.29e-05	0.00177	CbGpPWpGaD
Methdilazine—Mequitazine—CYP2D6—epilepsy syndrome	2.28e-05	0.00607	CrCbGaD
Methdilazine—Desipramine—CHRM2—epilepsy syndrome	2.25e-05	0.006	CrCbGaD
Methdilazine—Thioridazine—ADRA2A—epilepsy syndrome	2.25e-05	0.006	CrCbGaD
Methdilazine—HRH1—GPCR ligand binding—CXCL12—epilepsy syndrome	2.24e-05	0.00174	CbGpPWpGaD
Methdilazine—HRH1—GPCR ligand binding—BDKRB2—epilepsy syndrome	2.24e-05	0.00174	CbGpPWpGaD
Methdilazine—HRH1—Signaling by GPCR—ARHGEF9—epilepsy syndrome	2.24e-05	0.00173	CbGpPWpGaD
Methdilazine—HRH1—Signaling by GPCR—CCR8—epilepsy syndrome	2.24e-05	0.00173	CbGpPWpGaD
Methdilazine—HRH1—Signaling by GPCR—NPY2R—epilepsy syndrome	2.24e-05	0.00173	CbGpPWpGaD
Methdilazine—HRH1—Signaling by GPCR—SSTR1—epilepsy syndrome	2.24e-05	0.00173	CbGpPWpGaD
Methdilazine—HRH1—Signaling by GPCR—CCR9—epilepsy syndrome	2.24e-05	0.00173	CbGpPWpGaD
Methdilazine—HRH1—GPCR ligand binding—CNR1—epilepsy syndrome	2.2e-05	0.00171	CbGpPWpGaD
Methdilazine—Trimipramine—ADRA2A—epilepsy syndrome	2.2e-05	0.00586	CrCbGaD
Methdilazine—HRH1—Signaling by GPCR—GRM4—epilepsy syndrome	2.19e-05	0.0017	CbGpPWpGaD
Methdilazine—HRH1—Signaling by GPCR—GRM3—epilepsy syndrome	2.19e-05	0.0017	CbGpPWpGaD
Methdilazine—Pipotiazine—CYP2C19—epilepsy syndrome	2.19e-05	0.00583	CrCbGaD
Methdilazine—HRH1—GPCR downstream signaling—OPRD1—epilepsy syndrome	2.18e-05	0.00169	CbGpPWpGaD
Methdilazine—Promazine—CHRM2—epilepsy syndrome	2.18e-05	0.00582	CrCbGaD
Methdilazine—HRH1—Signaling by GPCR—SSTR2—epilepsy syndrome	2.15e-05	0.00167	CbGpPWpGaD
Methdilazine—HRH1—GPCR ligand binding—HTR7—epilepsy syndrome	2.15e-05	0.00167	CbGpPWpGaD
Methdilazine—Methotrimeprazine—ADRA2A—epilepsy syndrome	2.15e-05	0.00573	CrCbGaD
Methdilazine—HRH1—GPCR downstream signaling—PDYN—epilepsy syndrome	2.09e-05	0.00162	CbGpPWpGaD
Methdilazine—HRH1—GPCR downstream signaling—CCR7—epilepsy syndrome	2.09e-05	0.00162	CbGpPWpGaD
Methdilazine—HRH1—GPCR downstream signaling—GRM1—epilepsy syndrome	2.09e-05	0.00162	CbGpPWpGaD
Methdilazine—HRH1—GPCR downstream signaling—CHRM1—epilepsy syndrome	2.09e-05	0.00162	CbGpPWpGaD
Methdilazine—Mirtazapine—HTR2A—epilepsy syndrome	2.08e-05	0.00556	CrCbGaD
Methdilazine—HRH1—Signaling by GPCR—GRM8—epilepsy syndrome	2.08e-05	0.00161	CbGpPWpGaD
Methdilazine—Perphenazine—ADRA2A—epilepsy syndrome	2.07e-05	0.00551	CrCbGaD
Methdilazine—Carbamazepine—CYP2C19—epilepsy syndrome	2.05e-05	0.00547	CrCbGaD
Methdilazine—Quetiapine—ADRA2A—epilepsy syndrome	2.03e-05	0.0054	CrCbGaD
Methdilazine—Cyproheptadine—HTR2A—epilepsy syndrome	2.02e-05	0.00539	CrCbGaD
Methdilazine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR5—epilepsy syndrome	2.02e-05	0.00157	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—ACKR4—epilepsy syndrome	2.01e-05	0.00156	CbGpPWpGaD
Methdilazine—Mianserin—SLC6A4—epilepsy syndrome	1.99e-05	0.00531	CrCbGaD
Methdilazine—HRH1—Signaling by GPCR—OPRD1—epilepsy syndrome	1.98e-05	0.00154	CbGpPWpGaD
Methdilazine—HRH1—Signaling by GPCR—GNAO1—epilepsy syndrome	1.98e-05	0.00154	CbGpPWpGaD
Methdilazine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—epilepsy syndrome	1.98e-05	0.00153	CbGpPWpGaD
Methdilazine—HRH1—GPCR downstream signaling—GAL—epilepsy syndrome	1.97e-05	0.00153	CbGpPWpGaD
Methdilazine—HRH1—GPCR downstream signaling—GRM5—epilepsy syndrome	1.95e-05	0.00151	CbGpPWpGaD
Methdilazine—HRH1—GPCR downstream signaling—CHRM3—epilepsy syndrome	1.95e-05	0.00151	CbGpPWpGaD
Methdilazine—Chlorpromazine—CHRM2—epilepsy syndrome	1.92e-05	0.00512	CrCbGaD
Methdilazine—Chlorpromazine—HTR7—epilepsy syndrome	1.91e-05	0.00509	CrCbGaD
Methdilazine—Imipramine—CHRM2—epilepsy syndrome	1.91e-05	0.00509	CrCbGaD
Methdilazine—Mirtazapine—CYP2D6—epilepsy syndrome	1.91e-05	0.00508	CrCbGaD
Methdilazine—Imipramine—HTR7—epilepsy syndrome	1.9e-05	0.00507	CrCbGaD
Methdilazine—HRH1—Signaling by GPCR—PDYN—epilepsy syndrome	1.9e-05	0.00147	CbGpPWpGaD
Methdilazine—HRH1—Signaling by GPCR—GRM1—epilepsy syndrome	1.9e-05	0.00147	CbGpPWpGaD
Methdilazine—HRH1—Signaling by GPCR—CCR7—epilepsy syndrome	1.9e-05	0.00147	CbGpPWpGaD
Methdilazine—HRH1—Signaling by GPCR—CHRM1—epilepsy syndrome	1.9e-05	0.00147	CbGpPWpGaD
Methdilazine—HRH1—Class A/1 (Rhodopsin-like receptors)—AGT—epilepsy syndrome	1.88e-05	0.00145	CbGpPWpGaD
Methdilazine—Promazine—ADRA2A—epilepsy syndrome	1.86e-05	0.00496	CrCbGaD
Methdilazine—Acepromazine—HTR2A—epilepsy syndrome	1.84e-05	0.00491	CrCbGaD
Methdilazine—HRH1—GPCR downstream signaling—BDKRB1—epilepsy syndrome	1.83e-05	0.00142	CbGpPWpGaD
Methdilazine—HRH1—GPCR downstream signaling—CHRM2—epilepsy syndrome	1.83e-05	0.00142	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—SSTR4—epilepsy syndrome	1.82e-05	0.00141	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—SSTR5—epilepsy syndrome	1.82e-05	0.00141	CbGpPWpGaD
Methdilazine—HRH1—GPCR ligand binding—AVP—epilepsy syndrome	1.81e-05	0.0014	CbGpPWpGaD
Methdilazine—Thioproperazine—HTR2A—epilepsy syndrome	1.8e-05	0.0048	CrCbGaD
Methdilazine—HRH1—Signaling by GPCR—GAL—epilepsy syndrome	1.79e-05	0.00139	CbGpPWpGaD
Methdilazine—HRH1—GPCR downstream signaling—GABBR1—epilepsy syndrome	1.78e-05	0.00138	CbGpPWpGaD
Methdilazine—Pipotiazine—HTR2A—epilepsy syndrome	1.77e-05	0.00472	CrCbGaD
Methdilazine—HRH1—Signaling by GPCR—CHRM3—epilepsy syndrome	1.77e-05	0.00137	CbGpPWpGaD
Methdilazine—HRH1—Signaling by GPCR—GRM5—epilepsy syndrome	1.77e-05	0.00137	CbGpPWpGaD
Methdilazine—Mesoridazine—HTR2A—epilepsy syndrome	1.75e-05	0.00466	CrCbGaD
Methdilazine—HRH1—Signaling Pathways—CCR10—epilepsy syndrome	1.74e-05	0.00135	CbGpPWpGaD
Methdilazine—Epinastine—ABCB1—epilepsy syndrome	1.73e-05	0.00461	CrCbGaD
Methdilazine—HRH1—GPCR downstream signaling—HRH3—epilepsy syndrome	1.71e-05	0.00132	CbGpPWpGaD
Methdilazine—HRH1—Signaling by GPCR—CX3CR1—epilepsy syndrome	1.69e-05	0.00131	CbGpPWpGaD
Methdilazine—HRH1—GPCR downstream signaling—OPRM1—epilepsy syndrome	1.68e-05	0.0013	CbGpPWpGaD
Methdilazine—Trimipramine—SLC6A4—epilepsy syndrome	1.68e-05	0.00447	CrCbGaD
Methdilazine—Oxcarbazepine—ALB—epilepsy syndrome	1.67e-05	0.00445	CrCbGaD
Methdilazine—HRH1—Signaling by GPCR—BDKRB1—epilepsy syndrome	1.66e-05	0.00129	CbGpPWpGaD
Methdilazine—HRH1—Signaling by GPCR—CHRM2—epilepsy syndrome	1.66e-05	0.00129	CbGpPWpGaD
Methdilazine—HRH1—Signaling by GPCR—CX3CL1—epilepsy syndrome	1.66e-05	0.00129	CbGpPWpGaD
Methdilazine—Chlorpromazine—ADRA2A—epilepsy syndrome	1.64e-05	0.00437	CrCbGaD
Methdilazine—Thioridazine—CYP2C19—epilepsy syndrome	1.63e-05	0.00434	CrCbGaD
Methdilazine—Pipotiazine—CYP2D6—epilepsy syndrome	1.62e-05	0.00432	CrCbGaD
Methdilazine—HRH1—Signaling by GPCR—GABBR1—epilepsy syndrome	1.62e-05	0.00125	CbGpPWpGaD
Methdilazine—Chlorpromazine—BCHE—epilepsy syndrome	1.6e-05	0.00427	CrCbGaD
Methdilazine—Mesoridazine—CYP2D6—epilepsy syndrome	1.6e-05	0.00426	CrCbGaD
Methdilazine—Trimipramine—CYP2C19—epilepsy syndrome	1.59e-05	0.00424	CrCbGaD
Methdilazine—HRH1—GPCR downstream signaling—CCR3—epilepsy syndrome	1.59e-05	0.00123	CbGpPWpGaD
Methdilazine—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—epilepsy syndrome	1.58e-05	0.00122	CbGpPWpGaD
Methdilazine—HRH1—Signaling by GPCR—HRH3—epilepsy syndrome	1.55e-05	0.0012	CbGpPWpGaD
Methdilazine—Prochlorperazine—CYP2D6—epilepsy syndrome	1.55e-05	0.00413	CrCbGaD
Methdilazine—HRH1—GPCR downstream signaling—NPY—epilepsy syndrome	1.55e-05	0.0012	CbGpPWpGaD
Methdilazine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL2—epilepsy syndrome	1.54e-05	0.0012	CbGpPWpGaD
Methdilazine—HRH1—GPCR ligand binding—CCR5—epilepsy syndrome	1.54e-05	0.00119	CbGpPWpGaD
Methdilazine—Fluphenazine—HTR2A—epilepsy syndrome	1.53e-05	0.00408	CrCbGaD
Methdilazine—Mianserin—HTR2A—epilepsy syndrome	1.53e-05	0.00408	CrCbGaD
Methdilazine—HRH1—Signaling by GPCR—OPRM1—epilepsy syndrome	1.53e-05	0.00118	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—GRM2—epilepsy syndrome	1.52e-05	0.00118	CbGpPWpGaD
Methdilazine—HRH1—GPCR ligand binding—HTR2A—epilepsy syndrome	1.51e-05	0.00117	CbGpPWpGaD
Methdilazine—Perphenazine—CYP2C19—epilepsy syndrome	1.49e-05	0.00398	CrCbGaD
Methdilazine—HRH1—GPCR downstream signaling—CRH—epilepsy syndrome	1.49e-05	0.00116	CbGpPWpGaD
Methdilazine—HRH1—GPCR downstream signaling—OXT—epilepsy syndrome	1.49e-05	0.00116	CbGpPWpGaD
Methdilazine—HRH1—GPCR downstream signaling—CXCL2—epilepsy syndrome	1.49e-05	0.00116	CbGpPWpGaD
Methdilazine—Propiomazine—HTR2A—epilepsy syndrome	1.47e-05	0.00393	CrCbGaD
Methdilazine—Desipramine—SLC6A4—epilepsy syndrome	1.47e-05	0.00391	CrCbGaD
Methdilazine—Quetiapine—CYP2C19—epilepsy syndrome	1.47e-05	0.0039	CrCbGaD
Methdilazine—HRH1—Signaling by GPCR—CCR3—epilepsy syndrome	1.44e-05	0.00112	CbGpPWpGaD
Methdilazine—HRH1—GPCR ligand binding—AGT—epilepsy syndrome	1.43e-05	0.00111	CbGpPWpGaD
Methdilazine—HRH1—Signaling by GPCR—NPY—epilepsy syndrome	1.4e-05	0.00109	CbGpPWpGaD
Methdilazine—Fluphenazine—CYP2D6—epilepsy syndrome	1.4e-05	0.00373	CrCbGaD
Methdilazine—Mianserin—CYP2D6—epilepsy syndrome	1.4e-05	0.00373	CrCbGaD
Methdilazine—Desipramine—CYP2C19—epilepsy syndrome	1.39e-05	0.00371	CrCbGaD
Methdilazine—HRH1—Signaling Pathways—SSTR3—epilepsy syndrome	1.38e-05	0.00107	CbGpPWpGaD
Methdilazine—HRH1—Signaling by GPCR—CCL3—epilepsy syndrome	1.35e-05	0.00105	CbGpPWpGaD
Methdilazine—HRH1—Signaling by GPCR—OXT—epilepsy syndrome	1.35e-05	0.00105	CbGpPWpGaD
Methdilazine—HRH1—Signaling by GPCR—CXCL2—epilepsy syndrome	1.35e-05	0.00105	CbGpPWpGaD
Methdilazine—HRH1—Signaling by GPCR—CRH—epilepsy syndrome	1.35e-05	0.00105	CbGpPWpGaD
Methdilazine—HRH1—GPCR downstream signaling—SST—epilepsy syndrome	1.35e-05	0.00105	CbGpPWpGaD
Methdilazine—HRH1—GPCR downstream signaling—CCR2—epilepsy syndrome	1.35e-05	0.00105	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—ST3GAL3—epilepsy syndrome	1.35e-05	0.00105	CbGpPWpGaD
Methdilazine—Promazine—CYP2C19—epilepsy syndrome	1.35e-05	0.00359	CrCbGaD
Methdilazine—HRH1—Signaling Pathways—ARHGEF9—epilepsy syndrome	1.32e-05	0.00102	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—SSTR1—epilepsy syndrome	1.32e-05	0.00102	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—CCR8—epilepsy syndrome	1.32e-05	0.00102	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—CCR9—epilepsy syndrome	1.32e-05	0.00102	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—NPY2R—epilepsy syndrome	1.32e-05	0.00102	CbGpPWpGaD
Methdilazine—HRH1—GPCR downstream signaling—ADRA2A—epilepsy syndrome	1.32e-05	0.00102	CbGpPWpGaD
Methdilazine—Thioridazine—HTR2A—epilepsy syndrome	1.32e-05	0.00352	CrCbGaD
Methdilazine—Triflupromazine—ABCB1—epilepsy syndrome	1.3e-05	0.00347	CrCbGaD
Methdilazine—HRH1—Signaling Pathways—GRM3—epilepsy syndrome	1.3e-05	0.001	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—GRM4—epilepsy syndrome	1.3e-05	0.001	CbGpPWpGaD
Methdilazine—Trimipramine—HTR2A—epilepsy syndrome	1.29e-05	0.00344	CrCbGaD
Methdilazine—HRH1—Signaling Pathways—DUSP4—epilepsy syndrome	1.27e-05	0.000986	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—SSTR2—epilepsy syndrome	1.27e-05	0.000986	CbGpPWpGaD
Methdilazine—HRH1—GPCR downstream signaling—BDKRB2—epilepsy syndrome	1.27e-05	0.000983	CbGpPWpGaD
Methdilazine—HRH1—GPCR downstream signaling—CXCL12—epilepsy syndrome	1.27e-05	0.000983	CbGpPWpGaD
Methdilazine—Acepromazine—ALB—epilepsy syndrome	1.26e-05	0.00336	CrCbGaD
Methdilazine—Methotrimeprazine—HTR2A—epilepsy syndrome	1.26e-05	0.00336	CrCbGaD
Methdilazine—HRH1—GPCR downstream signaling—CNR1—epilepsy syndrome	1.25e-05	0.000965	CbGpPWpGaD
Methdilazine—Imipramine—SLC6A4—epilepsy syndrome	1.24e-05	0.00332	CrCbGaD
Methdilazine—Promethazine—HTR2A—epilepsy syndrome	1.24e-05	0.00331	CrCbGaD
Methdilazine—HRH1—GPCR downstream signaling—PLCB1—epilepsy syndrome	1.24e-05	0.000962	CbGpPWpGaD
Methdilazine—Thioproperazine—ALB—epilepsy syndrome	1.23e-05	0.00329	CrCbGaD
Methdilazine—HRH1—Signaling Pathways—GRM8—epilepsy syndrome	1.23e-05	0.000952	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—PGF—epilepsy syndrome	1.23e-05	0.000952	CbGpPWpGaD
Methdilazine—HRH1—Signaling by GPCR—CCR2—epilepsy syndrome	1.23e-05	0.00095	CbGpPWpGaD
Methdilazine—HRH1—Signaling by GPCR—SST—epilepsy syndrome	1.23e-05	0.00095	CbGpPWpGaD
Methdilazine—Trifluoperazine—HTR2A—epilepsy syndrome	1.22e-05	0.00326	CrCbGaD
Methdilazine—HRH1—GPCR downstream signaling—HTR7—epilepsy syndrome	1.21e-05	0.000942	CbGpPWpGaD
Methdilazine—Pipotiazine—ALB—epilepsy syndrome	1.21e-05	0.00323	CrCbGaD
Methdilazine—Perphenazine—HTR2A—epilepsy syndrome	1.21e-05	0.00323	CrCbGaD
Methdilazine—Thioridazine—CYP2D6—epilepsy syndrome	1.21e-05	0.00322	CrCbGaD
Methdilazine—HRH1—GPCR ligand binding—POMC—epilepsy syndrome	1.2e-05	0.000932	CbGpPWpGaD
Methdilazine—HRH1—Signaling by GPCR—ADRA2A—epilepsy syndrome	1.2e-05	0.000929	CbGpPWpGaD
Methdilazine—Quetiapine—HTR2A—epilepsy syndrome	1.19e-05	0.00317	CrCbGaD
Methdilazine—Imipramine—CYP2C19—epilepsy syndrome	1.18e-05	0.00314	CrCbGaD
Methdilazine—Trimipramine—CYP2D6—epilepsy syndrome	1.18e-05	0.00314	CrCbGaD
Methdilazine—HRH1—GPCR ligand binding—CCL2—epilepsy syndrome	1.18e-05	0.000912	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—GNAO1—epilepsy syndrome	1.17e-05	0.000908	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—OPRD1—epilepsy syndrome	1.17e-05	0.000908	CbGpPWpGaD
Methdilazine—HRH1—GPCR downstream signaling—AKT3—epilepsy syndrome	1.16e-05	0.000897	CbGpPWpGaD
Methdilazine—Methotrimeprazine—CYP2D6—epilepsy syndrome	1.15e-05	0.00307	CrCbGaD
Methdilazine—HRH1—Signaling by GPCR—CXCL12—epilepsy syndrome	1.15e-05	0.000893	CbGpPWpGaD
Methdilazine—HRH1—Signaling by GPCR—BDKRB2—epilepsy syndrome	1.15e-05	0.000893	CbGpPWpGaD
Methdilazine—Promethazine—CYP2D6—epilepsy syndrome	1.14e-05	0.00303	CrCbGaD
Methdilazine—HRH1—Signaling by GPCR—CNR1—epilepsy syndrome	1.13e-05	0.000876	CbGpPWpGaD
Methdilazine—Desipramine—HTR2A—epilepsy syndrome	1.13e-05	0.003	CrCbGaD
Methdilazine—HRH1—Signaling by GPCR—PLCB1—epilepsy syndrome	1.13e-05	0.000873	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—GRM1—epilepsy syndrome	1.12e-05	0.000871	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—CHRM1—epilepsy syndrome	1.12e-05	0.000871	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—CCR7—epilepsy syndrome	1.12e-05	0.000871	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—PDYN—epilepsy syndrome	1.12e-05	0.000871	CbGpPWpGaD
Methdilazine—Perphenazine—CYP2D6—epilepsy syndrome	1.11e-05	0.00295	CrCbGaD
Methdilazine—HRH1—Signaling by GPCR—HTR7—epilepsy syndrome	1.1e-05	0.000855	CbGpPWpGaD
Methdilazine—Promazine—HTR2A—epilepsy syndrome	1.09e-05	0.00291	CrCbGaD
Methdilazine—Quetiapine—CYP2D6—epilepsy syndrome	1.09e-05	0.0029	CrCbGaD
Methdilazine—Carbamazepine—ABCB1—epilepsy syndrome	1.09e-05	0.00289	CrCbGaD
Methdilazine—HRH1—Signaling by GPCR—HBEGF—epilepsy syndrome	1.07e-05	0.00083	CbGpPWpGaD
Methdilazine—HRH1—GPCR downstream signaling—CDC42—epilepsy syndrome	1.06e-05	0.000819	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—GAL—epilepsy syndrome	1.06e-05	0.000819	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—GFAP—epilepsy syndrome	1.06e-05	0.000819	CbGpPWpGaD
Methdilazine—HRH1—Signaling by GPCR—AKT3—epilepsy syndrome	1.05e-05	0.000815	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—GRM5—epilepsy syndrome	1.04e-05	0.000809	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—CHRM3—epilepsy syndrome	1.04e-05	0.000809	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—CASP2—epilepsy syndrome	1.04e-05	0.000809	CbGpPWpGaD
Methdilazine—Desipramine—CYP2D6—epilepsy syndrome	1.03e-05	0.00275	CrCbGaD
Methdilazine—HRH1—GPCR downstream signaling—AVP—epilepsy syndrome	1.02e-05	0.000793	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—CX3CR1—epilepsy syndrome	1e-05	0.000776	CbGpPWpGaD
Methdilazine—Fluphenazine—ABCB1—epilepsy syndrome	1e-05	0.00267	CrCbGaD
Methdilazine—HRH1—Signaling Pathways—BDKRB1—epilepsy syndrome	9.82e-06	0.000761	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—CHRM2—epilepsy syndrome	9.82e-06	0.000761	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—CX3CL1—epilepsy syndrome	9.82e-06	0.000761	CbGpPWpGaD
Methdilazine—Chlorpromazine—HTR2A—epilepsy syndrome	9.61e-06	0.00256	CrCbGaD
Methdilazine—HRH1—Signaling by GPCR—CDC42—epilepsy syndrome	9.59e-06	0.000743	CbGpPWpGaD
Methdilazine—Imipramine—HTR2A—epilepsy syndrome	9.56e-06	0.00255	CrCbGaD
Methdilazine—HRH1—Signaling Pathways—GABBR1—epilepsy syndrome	9.55e-06	0.00074	CbGpPWpGaD
Methdilazine—HRH1—Signaling by GPCR—AVP—epilepsy syndrome	9.29e-06	0.00072	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—HRH3—epilepsy syndrome	9.16e-06	0.00071	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—OPRM1—epilepsy syndrome	9.01e-06	0.000699	CbGpPWpGaD
Methdilazine—Chlorpromazine—CYP2D6—epilepsy syndrome	8.79e-06	0.00234	CrCbGaD
Methdilazine—Imipramine—CYP2D6—epilepsy syndrome	8.74e-06	0.00233	CrCbGaD
Methdilazine—HRH1—GPCR downstream signaling—CCR5—epilepsy syndrome	8.69e-06	0.000674	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—CCR3—epilepsy syndrome	8.51e-06	0.00066	CbGpPWpGaD
Methdilazine—HRH1—GPCR downstream signaling—HTR2A—epilepsy syndrome	8.51e-06	0.000659	CbGpPWpGaD
Methdilazine—Trimipramine—ABCB1—epilepsy syndrome	8.42e-06	0.00224	CrCbGaD
Methdilazine—HRH1—Signaling Pathways—NPY—epilepsy syndrome	8.3e-06	0.000643	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—ATP2A2—epilepsy syndrome	8.3e-06	0.000643	CbGpPWpGaD
Methdilazine—Promethazine—ABCB1—epilepsy syndrome	8.11e-06	0.00216	CrCbGaD
Methdilazine—HRH1—GPCR downstream signaling—AGT—epilepsy syndrome	8.07e-06	0.000626	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—HSPB1—epilepsy syndrome	8e-06	0.00062	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—CCL3—epilepsy syndrome	8e-06	0.00062	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—CXCL2—epilepsy syndrome	8e-06	0.00062	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—OXT—epilepsy syndrome	8e-06	0.00062	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—CRH—epilepsy syndrome	8e-06	0.00062	CbGpPWpGaD
Methdilazine—Trifluoperazine—ABCB1—epilepsy syndrome	8e-06	0.00213	CrCbGaD
Methdilazine—HRH1—Signaling by GPCR—CCR5—epilepsy syndrome	7.9e-06	0.000612	CbGpPWpGaD
Methdilazine—Quetiapine—ABCB1—epilepsy syndrome	7.76e-06	0.00207	CrCbGaD
Methdilazine—HRH1—Signaling by GPCR—HTR2A—epilepsy syndrome	7.73e-06	0.000599	CbGpPWpGaD
Methdilazine—HRH1—GPCR downstream signaling—PRKCB—epilepsy syndrome	7.46e-06	0.000578	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—TSC1—epilepsy syndrome	7.44e-06	0.000577	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—PTK2B—epilepsy syndrome	7.44e-06	0.000577	CbGpPWpGaD
Methdilazine—Desipramine—ABCB1—epilepsy syndrome	7.36e-06	0.00196	CrCbGaD
Methdilazine—HRH1—Signaling by GPCR—AGT—epilepsy syndrome	7.33e-06	0.000568	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—SST—epilepsy syndrome	7.24e-06	0.000561	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—CCR2—epilepsy syndrome	7.24e-06	0.000561	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—NTRK2—epilepsy syndrome	7.24e-06	0.000561	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—DUSP6—epilepsy syndrome	7.17e-06	0.000556	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—ADRA2A—epilepsy syndrome	7.08e-06	0.000549	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—PLAT—epilepsy syndrome	7.05e-06	0.000547	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—BDKRB2—epilepsy syndrome	6.8e-06	0.000527	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—CXCL12—epilepsy syndrome	6.8e-06	0.000527	CbGpPWpGaD
Methdilazine—HRH1—GPCR downstream signaling—POMC—epilepsy syndrome	6.8e-06	0.000527	CbGpPWpGaD
Methdilazine—HRH1—Signaling by GPCR—PRKCB—epilepsy syndrome	6.77e-06	0.000525	CbGpPWpGaD
Methdilazine—HRH1—Signaling by GPCR—IL6ST—epilepsy syndrome	6.75e-06	0.000523	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—JUNB—epilepsy syndrome	6.68e-06	0.000518	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—CNR1—epilepsy syndrome	6.68e-06	0.000518	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—PLCB1—epilepsy syndrome	6.66e-06	0.000516	CbGpPWpGaD
Methdilazine—Chlorpromazine—ALB—epilepsy syndrome	6.58e-06	0.00175	CrCbGaD
Methdilazine—HRH1—Signaling Pathways—HTR7—epilepsy syndrome	6.52e-06	0.000505	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—HBEGF—epilepsy syndrome	6.33e-06	0.00049	CbGpPWpGaD
Methdilazine—Chlorpromazine—ABCB1—epilepsy syndrome	6.28e-06	0.00167	CrCbGaD
Methdilazine—Imipramine—ABCB1—epilepsy syndrome	6.24e-06	0.00166	CrCbGaD
Methdilazine—HRH1—Signaling Pathways—AKT3—epilepsy syndrome	6.21e-06	0.000481	CbGpPWpGaD
Methdilazine—HRH1—Signaling by GPCR—POMC—epilepsy syndrome	6.17e-06	0.000478	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—ADAM10—epilepsy syndrome	6.07e-06	0.00047	CbGpPWpGaD
Methdilazine—HRH1—Signaling by GPCR—CCL2—epilepsy syndrome	6.04e-06	0.000468	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—S100B—epilepsy syndrome	5.74e-06	0.000445	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—SOCS3—epilepsy syndrome	5.68e-06	0.00044	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—CDC42—epilepsy syndrome	5.67e-06	0.000439	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—AVP—epilepsy syndrome	5.49e-06	0.000425	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—HES1—epilepsy syndrome	5.19e-06	0.000402	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—FYN—epilepsy syndrome	5.04e-06	0.000391	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—H2AFX—epilepsy syndrome	5.03e-06	0.00039	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—MEF2C—epilepsy syndrome	5.02e-06	0.000389	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—YWHAZ—epilepsy syndrome	4.85e-06	0.000376	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—NGF—epilepsy syndrome	4.79e-06	0.000372	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—CCR5—epilepsy syndrome	4.66e-06	0.000361	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—HTR2A—epilepsy syndrome	4.56e-06	0.000354	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—TSC2—epilepsy syndrome	4.34e-06	0.000336	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—AGT—epilepsy syndrome	4.33e-06	0.000336	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—APOE—epilepsy syndrome	4.24e-06	0.000329	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—KDR—epilepsy syndrome	4.16e-06	0.000322	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—PRKCB—epilepsy syndrome	4e-06	0.00031	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—IL6ST—epilepsy syndrome	3.99e-06	0.000309	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—POMC—epilepsy syndrome	3.65e-06	0.000283	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—CCL2—epilepsy syndrome	3.57e-06	0.000276	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—FGF2—epilepsy syndrome	3.22e-06	0.00025	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—RELA—epilepsy syndrome	2.99e-06	0.000232	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—MTOR—epilepsy syndrome	2.93e-06	0.000227	CbGpPWpGaD
Methdilazine—HRH1—GPCR downstream signaling—AKT1—epilepsy syndrome	2.72e-06	0.000211	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—CASP3—epilepsy syndrome	2.7e-06	0.000209	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—JUN—epilepsy syndrome	2.62e-06	0.000203	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—MMP9—epilepsy syndrome	2.55e-06	0.000198	CbGpPWpGaD
Methdilazine—HRH1—Signaling by GPCR—AKT1—epilepsy syndrome	2.47e-06	0.000192	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—SRC—epilepsy syndrome	2.35e-06	0.000182	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—VEGFA—epilepsy syndrome	2.29e-06	0.000178	CbGpPWpGaD
Methdilazine—HRH1—Signaling Pathways—AKT1—epilepsy syndrome	1.46e-06	0.000113	CbGpPWpGaD
